Corporate Governance

en

Language

Corporate Governance

           Investor Day 2023
Watch Video                        

"Iconic Solutions for Your Health and Wellness”

           Investor Day 2023
Watch Video                        

"Iconic Solutions for Your Health and Wellness”

           Investor Day 2023
Watch Video                        

"Iconic Solutions for Your Health and Wellness”

           Investor Day 2023
Watch Video                        

"Iconic Solutions for Your Health and Wellness”

           Investor Day 2023
Watch Video                        

"Iconic Solutions for Your Health and Wellness”

           Investor Day 2023
Watch Video                        

"Iconic Solutions for Your Health and Wellness”

  • Shareholders' Meeting Information
    (Proxy Documents)

    PROXY 2025 - Genomma Lab nominees for Board of Directors and Committees to serve from April 2025 to April 2026

    pdf

    PROXY 2025 - Genomma Lab Informs The Dividend Proposal

    pdf

    PROXY 2025 - Genomma Lab informs the amount to be proposed to the Shareholder’s Meeting for the 2025 Share Buyback Program

    pdf

    PROXY 2025 - Genomma Lab informs the amount to be proposed of remuneration for the Board of Directors and The Audit & Corporate Practices Committee Members

    pdf

    PROXY 2024 - Genomma Lab Informs The Corporate Bond (Cebures) Program Proposal

    pdf

    PROXY 2024 - Genomma Lab Informs The Dividend Proposal

    pdf

    PROXY 2024 - Genomma Lab Informs The Amount To Be Proposed To The Shareholder’s Meeting For The Cancellation Of Buyback Shares

    pdf

    PROXY 2024 - Genomma Lab informs the amount to be proposed to the Shareholder’s Meeting for the 2024 Share Buyback Program

    pdf

    PROXY 2024 - Genomma Lab informs the amount to be proposed of remuneration for the Board of Directors and The Audit & Corporate Practices Committee Members

    pdf

    PROXY 2024 - Genomma Lab nominees for Board of Directors and Committees to serve from April 2024 to April 2025

    pdf

    PROXY 2023 - Genomma Lab nominees for Board of Directors and Committees to serve from April 2023 to April 2024

    pdf

    PROXY 2023 - Genomma Lab informs the amount to be proposed of remuneration for the Board of Directors and The Audit & Corporate Practices Committee Members

    pdf

    PROXY 2023 - Genomma Lab informs the amount to be proposed to the Shareholder’s Meeting for the 2023 Share Buyback Program

    pdf

    PROXY 2023 - Genomma Lab Informs The Amount To Be Proposed To The Shareholder’s Meeting For The Cancellation Of Buyback Shares

    pdf

Genomma Lab is committed to enriching the well-being of our society by improving life quality of the consumers of our products via the investigation and analysis of the optimal ingredients for the development and commercialization of our personal care and OTC pharmaceutical products, and in so doing, generating the maximum levels of profitability possible for our investors.

Rodrigo Herrera Aspra

Founder and Chairman of the Board

Corporate Governance

Board Of Directors

  • Rodrigo Alonso Herrera Aspra

    Chairman

  • Simona Visztova

    Independent Board Member

  • Joaquín Ley Pinto

    Independent Board Member

  • Jorge Brake Valderrama

    Propietary Board Member

  • Marco Francisco Forastieri Muñoz

    Proprietary Independent Board Member

  • Carlos Javier Vara Alonso

    Independent Board Member

  • Juan Carlos Gavito Aspe

    Independent Board Member

  • Ignacio González Rodríguez

    Independent Board Member

  • Javier Vale Castilla

    Independent Board Member

  • Jorge Ricardo Gutiérrez Muñoz

    Independent Board Member

  • Sabrina Lucila Herrera Aspra

    Related Board Member

  • Juan Alonso

    Independent Board Member

Auditing and Corporate Practices Committee

  • Jorge Ricardo Gutiérrez Muñoz

    President

  • Juan Carlos Gavito Aspe

    Independent Board Member

  • Juan Alonso

    Independent Board Member

Executive Managment Team

  • Marco Sparvieri

    Chief Executive Officer

  • Antonio Zamora Galland

    Executive Vice-President and Chief Financial Officer

  • Alejandro Bastón Patiño

    Executive Vice-President of Media and Institutional Affairs

  • Policies and Code of Ethics

    Anti-corruption Policy

    pdf

    Integral Management Policy

    pdf

    Code of Ethics

    pdf

  • Company By-Laws

    pdf

Financial Information

Q2 2025 Annual 2024

Relevant Events

Sustainability

Web Page Report

Corporate Presentation

June, 2025

Our brands